Prostate cancer is a health issue that impacts individuals worldwide, and choosing the best treatment can be difficult, given ...

Prostate cancer ranks among the most common health challenges men face worldwide. While medical advances continue to improve treatment outcomes, the e ...

Amid rumors about Israeli PM Benjamin Netanyahu's prostate surgery, medical experts raise key questions about the procedure's ...

MRI-Guided Radiation Therapy Reduces Long-Term Side Effects for Patients ... in treating biochemically recurrent prostate cancer without accompanying hormone therapy for men who have mutations ...

Chemotherapy followed by hormone therapy is often used after surgery for breast cancer to help reduce the chances of it coming back ... The questionnaire will ask about side effects and how you’ve ...

Oral estrogens were the treatment of choice for carcinoma of the prostate for over four decades ... advantage of giving protection against the effects of andropause (similar to the female ...

Primarily used to screen for prostate cancer, PSA tests measure the level of prostate-specific antigen in the blood. “The ...

As with many cancers, early treatment is associated with not only better outcomes but a reduction in treatment-related side effects. Prostate cancer is the second most common cancer in men in the U.S.

Advanced Imaging Uncovers Hidden Metastases in High-Risk Prostate Cancer Cases Jan. 3, 2025 — A new study has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer ...

“Our findings highlight the coordinated interplay between GCN2 and p53 regulation during nutrient stress and provide insight into how they could be targeted in developing new therapeutic strategies ...

Jointly Bayer and Orion Corporation-developed NUBEQA (Darolutamide) + Androgen Deprivation Therapy (ADT ... patients with metastatic hormone-sensitive prostate cancer (mHSPC) and will be ...

Low testosterone (hypogonadism) is a condition where your body doesn’t produce enough of the hormone. It has several possible ...